Article
Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing.
JAMA - 25 Sept 2018
Mersch Jacqueline, Brown Nichole, Pirzadeh-Miller Sara, Mundt Erin, Cox Hannah C, Brown Krystal, Aston Melissa, Esterling Lisa, Manley Susan, Ross Theodora
Abstract excerpt
Importance: Variant reclassification is an important component of hereditary cancer genetic testing; however, there are few published data quantifying the prevalence of reclassification. Objective: Retrospective cohort study of individuals who had genetic testing from 2006 through 2016 at a single commercial laboratory. Design, Setting, and Participants: A retrospective cohort of individuals who had genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
